Skip to main content
. 2017 Dec 1;29(4):979–984. doi: 10.1093/annonc/mdx771

Figure 2.

Figure 2.

Best reduction from baseline in target lesions. Of the 36 patients, 27 patients (75%) showed tumor shrinkage relative to baseline.